JNJ Johnson & Johnson Earnings and EPS analysis

EPS in 2025 (TTM): $9.06

Last Report Period Date: Mar 30, 2025

As of July this year, based on Johnson & Johnson's most recent financial report, the company's trailing twelve months EPS is $9.06. Johnson & Johnson's earnings per share in 2024 was reported at $5.84, marking a decline from $13.88 in 2023. Johnson & Johnson's EPS for the quarterly period ending on Mar 30, 2025 came in at $4.57.

The yearly earnings per share during 2024 was $5.84, a decline of 57.9% compared to $13.88 recorded in 2023. The quarterly earnings per share for the period ending Mar 30, 2025, was $4.57, showing a 238.5% increase compared to the same quarter last year. The trailing twelve months EPS for JNJ is $9.06 as of March 2025. Johnson & Johnson's full-year EPS for 2023 was $13.88, a 103.2% rise compared to the previous year.

In the past 12 months, Johnson & Johnson has recorded an earnings per share growth rate of 238.5% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of -9.7% per year. In the last five years, the company had an average annual EPS growth of 0.4%. When assessed over a ten-year period, JNJ's average EPS annual growth was 0.1%.